Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.93B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.16B |
| 3 |
Albemarle
ALB
|
+$741M |
| 4 |
FRC
First Republic Bank
FRC
|
+$599M |
| 5 |
VICI Properties
VICI
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.16B |
| 2 |
Netflix
NFLX
|
+$1.04B |
| 3 |
Meta Platforms (Facebook)
META
|
+$872M |
| 4 |
EOG Resources
EOG
|
+$800M |
| 5 |
Intercontinental Exchange
ICE
|
+$700M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.46% |
| 2 | Healthcare | 16.89% |
| 3 | Financials | 14.17% |
| 4 | Communication Services | 10.18% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVA
251
DELISTED
Enviva Inc.
EVA
| $183M | 0.05% |
3,200,748
+3,014,282
| +1,617% | +$227M |
|
|
AESC
252
DELISTED
The AES Corporation
AESC
| $180M | 0.05% |
2,086,459
+1,300
| +0.1% | +$116K |
|
253
DexCom
DXCM
$34.2B
| $177M | 0.05% |
2,376,880
+72,128
| +3% | +$6.58M |
|
254
Genpact
G
$5.66B
| $169M | 0.05% |
3,987,597
+24,368
| +0.6% | +$1.03M |
|
255
Legend Biotech
LEGN
$3.95B
| $167M | 0.05% |
3,043,966
+233,229
| +8% | +$9.85M |
|
256
Pinterest
PINS
$13B
| $163M | 0.04% |
8,966,295
-2,858,813
| -24% | -$59.8M |
|
257
Aptiv
APTV
$10B
| $162M | 0.04% |
1,822,710
-1,473,412
| -45% | -$150M |
|
|
SUM
258
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $161M | 0.04% |
7,023,226
+1,975
| +0% | +$52.4K |
|
259
Advanced Drainage Systems
WMS
$11.2B
| $159M | 0.04% |
1,760,809
+1,199,231
| +214% | +$123M |
|
|
BLD
260
DELISTED
TopBuild
BLD
| $156M | 0.04% |
931,222
+17,292
| +2% | +$3.16M |
|
261
Everest Group
EG
$14B
| $154M | 0.04% |
548,156
-217,114
| -28% | -$61.4M |
|
262
Genmab
GMAB
$19.2B
| $149M | 0.04% |
4,697,095
+744,649
| +19% | +$24.1M |
|
263
Globant
GLOB
$1.7B
| $148M | 0.04% |
848,453
+25,821
| +3% | +$5.26M |
|
264
Huazhu Hotels Group
HTHT
$12.5B
| $147M | 0.04% |
3,864,618
-115,599
| -3% | -$3.62M |
|
265
Teradata
TDC
$2.5B
| $142M | 0.04% |
3,843,434
| – | – |
|
266
Amgen
AMGN
$226B
| $141M | 0.04% |
577,850
-57,138
| -9% | -$14M |
|
|
DHR.PRB
267
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| $141M | 0.04% |
106,241
-109,814
| -51% | -$155M |
|
268
DigitalBridge
DBRG
$2.94B
| $139M | 0.04% |
7,142,532
| – | – |
|
269
Lightspeed Commerce
LSPD
$1.37B
| $135M | 0.04% |
6,033,540
+471,563
| +8% | +$11.1M |
|
270
BWX Technologies
BWXT
$15.6B
| $134M | 0.04% |
2,438,755
| – | – |
|
271
Xcel Energy
XEL
$49.3B
| $131M | 0.04% |
1,854,622
-75,388
| -4% | -$5.48M |
|
272
Evertec
EVTC
$1.86B
| $131M | 0.04% |
3,557,079
+84,257
| +2% | +$3.22M |
|
273
HEICO Corp
HEI
$51.9B
| $131M | 0.04% |
999,497
-50,061
| -5% | -$7.05M |
|
|
KRTX
274
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $130M | 0.04% |
1,030,734
+927,859
| +902% | +$107M |
|
275
Enphase Energy
ENPH
$5.36B
| $129M | 0.04% |
659,283
+86
| +0% | +$15.5K |
|
Similar funds
Capital International Investors's Q2 2022 Portfolio in Review
As of Q2 2022, Capital International Investors held 470 positions worth $368B, down 16% from $439B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital International Investors's Q2 2022 filing shows 16 new, 197 increased, 171 reduced and 33 closed positions. Its largest new stake was Albemarle: 3,322,014 shares worth $694M. The largest sale was Eli Lilly, an estimated $1.16B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Capital International Investors's largest Q2 2022 buy was Albemarle: 3,322,014 shares worth $694M.
- Capital International Investors added most to AbbVie in Q2 2022, an estimated $1.93B increase.
- Capital International Investors's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $1.16B.
- Capital International Investors fully exited Marriott International in Q2 2022, selling an estimated $359M.
- Capital International Investors's ten largest holdings make up 27% of its $368B portfolio in Q2 2022.
- Capital International Investors opened 16 new positions and closed 33 in Q2 2022.
- Capital International Investors's portfolio value fell 16% quarter-over-quarter to $368B.
Based on Capital International Investors's 13F filing for Q2 2022, filed 15 Aug 2022.